Skip to content

Nuvalent, Inc. NUVL Total Assets

Total Assets at other companies

Pfizer logo
PfizerPFE
$207.62B-0.2%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$646.64M+113%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$647.86M+68.8%
Exelixis logo
ExelixisEXEL
$2.59B-8.6%
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
$2.25B-4.7%
Incyte logo
IncyteINCY
$7.34B+27.7%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Return on equity-41.2%+7.5pp
Current ratio16.1×+1.7×

Where this comes from

Reported directly by Nuvalent, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s total assets?
Nuvalent, Inc. (NUVL) reported total assets of $1.33B in Q1 2026.
How has Nuvalent, Inc.'s total assets changed year-over-year?
Nuvalent, Inc.'s total assets increased by 20.4% year-over-year, from $1.11B to $1.33B.
What is the long-term trend for Nuvalent, Inc.'s total assets?
Over 5 years (2020 to 2025), Nuvalent, Inc.'s total assets has grown at a 165.8% compound annual growth rate (CAGR), from $10.65M to $1.41B.
What does total assets mean?
The total value of everything the company owns.
How do you interpret total assets?
Growth in total assets generally reflects capital accumulation or investment in intellectual property and operational capacity.
How does total assets compare across companies?
Used to gauge the relative scale of the company compared to other clinical-stage biotech firms.